{"SPADE_UN_19790": {"Sequence Information": {"Peptide Name": "Toxin LyeTx 1 [H16Del]", "Sequence": "IWLTALKFLGKNLGKLAKQQLAKL", "Sequence Length": 24, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "6CL3", "UniProt Entry": [{"uniprotId": "C0HJU9", "uniprotUrl": "http://www.uniprot.org/uniprot/C0HJU9", "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."}], "Literature": [{"Title": "LyeTxI-b, a Synthetic Peptide Derived From Lycosa erythrognatha Spider Venom, Shows Potent Antibiotic Activity in Vitro and in Vivo.", "Pubmed ID": "29681894", "Reference": "Front Microbiol. 2018;9:667", "Author": "Reis PVM, Boff D, Verly RM, Melo-Braga MN, Cortés ME, Santos DM, Pimenta AMC, Amaral FA, Resende JM, de Lima ME", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29681894"}, {"Title": "The synthetic peptide LyeTxI-b derived from Lycosa erythrognatha spider venom is cytotoxic to U-87 MG glioblastoma cells", "Pubmed ID": "30449002", "Reference": "Amino Acids. 2018;51:433-449", "Author": "Abdel-Salam MAL, Carvalho-Tavares J, Gomes KS, Teixeira-Carvalho A, Kitten GT, Nyffeler J, Dias FF, Dos Reis PVM, Pimenta AMC, Leist M, de Lima ME, de Souza-Fagundes EM", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30449002"}], "Mass": 2696.32, "PI": 10.6, "Net Charge": 5, "Hydrophobicity": 0.29, "Frequent Amino Acids": "LKA", "Absent Amino Acids": "CDEHMOPRSUVY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 12, "Polar Residues": 12, "Positive Residues": 5, "Negative Residues": 0, "SPADE ID": "SPADE_UN_19790", "Similar Sequences": [{"SPADE_ID": "SPADE_N_05489", "Similarity": 1.0, "Sequence": "IWLTALKFLGKNLGKHLAKQQLAKL"}, {"SPADE_ID": "SPADE_UN_19790", "Similarity": 1.0, "Sequence": "IWLTALKFLGKNLGKLAKQQLAKL"}, {"SPADE_ID": "SPADE_UN_23083", "Similarity": 1.0, "Sequence": "IWLTALKFLGKNLGK"}], "Hemolytic Activity": "Sheep erythrocytes:46.83% Hemolysis=46.8 µM,Human PBMC:IC50=4.16 ± 1.94 µM,Vero cells:IC50=>100 µM,Human fibroblasts GM-637:IC50=>100 µM,Human erythrocytes:30-35% Hemolysis =100 µM", "Target Organism": "Escherichia coli ATCC 25922(MIC=0.71µM),Escherichia coli ATCC 25922(MBC=0.71µM),Staphylococcus aureus ATCC 25923(MIC=2.85µM),Staphylococcus aureus ATCC 25923(MBC=2.85µM),Aggregatibacter actinomycetemcomitans ATCC 29522(MIC=11.4µM),Aggregatibacter actinomycetemcomitans ATCC 29522(MBC=11.4µM),Streptococcus sanguinis ATCC 10556(MIC=5.7µM),Streptococcus sanguinis ATCC 10556(MBC=5.7µM),Human glioblastoma U87-MG(IC50=29.20 ± 7.96µM),Human neuroblastoma SH-SY5Y(IC50=93.80 ± 2.17µM),Human astrocytoma U373-MG(IC50=20.94 ± 5.18µM)"}}}